Patients with de novo or inherited c.842G>A p.(Arg281Gln) heterozygosity present with IFN activation and typical SAVI features such as ILD, failure to thrive, cough, dyspnea, and cutaneous necrotizing vasculitis (34–37). This evidence concerns the gene IFNA1 and Failure to thrive.